DBV TECHNOLOGIES
LIVE

Serial Number

79251242

Owner

DBV TECHNOLOGIES

Attorney

Anthony E. Bennett

Filing Date

Nov 6, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DBV TECHNOLOGIES Trademark

Serial Number: 79251242 • Registration: 5809654

DBV TECHNOLOGIES is a trademark filed by DBV TECHNOLOGIES on November 6, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DBV TECHNOLOGIES (42 trademarks)

177-181 avenue Pierre Brossolette
Montrouge 92120 , FR

Entity Type: 99

Trademark Details

Filing Date

November 6, 2018

Registration Date

July 23, 2019

Published for Opposition

May 7, 2019

Goods & Services

research in the field of immunotherapy; design of a scientific method for epicutaneous desensitization via immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of processing and treatment of allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin, other than simple and light cleaning in order to leave the cell structure of the skin intact, thus avoiding the transfer of the allergen into the blood; drug discovery being scientific research and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; design of methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact

medical apparatus, instruments and devices for the cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans or animals, namely, drug delivery patches sold without medication; occlusive dispenser for medical use sold without medication; medical instrument using electrostatic properties from a biocompatible support, namely epicutaneous patches sold without medication

[ adhesive patches enabling cutaneous or epicutaneous administration of powdered medicated or pharmaceutical substances for humans or animals featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases; drug delivery patch containing a preparation in powder form for medical use for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusive patch enabling the cutaneous absorption of a powdered medicated substance featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases ]

medical services applying a method for desensitizing by immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases via allergen administration by placing a patch on the patient's intact skin while preventing the allergen from getting into the blood; medical treatment of allergies, inflammatory and autoimmune diseases using a method for desensitizing by epicutaneous immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases by epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to combat allergies

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 20, 2026 INPR
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Aug 20, 2025 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Aug 20, 2025 15AK
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 20, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Aug 20, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 11, 2025 APRE
TEAS SECTION 71 RECEIVED
Jul 22, 2025 ES71
TEAS SECTION 15 RECEIVED
Jul 22, 2025 E15R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 16, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 16, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 16, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 16, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 16, 2024 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 23, 2024 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 13, 2024 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jun 15, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 1, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 6, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 15, 2019 FICS
FINAL DISPOSITION PROCESSED
Nov 15, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2019 NONP
REFUSAL PROCESSED BY IB
Mar 16, 2019 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2019 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 28, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 28, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 19, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 15, 2019 MAFR
ASSIGNED TO EXAMINER
Feb 11, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 7, 2019 REPR